US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

QURE

uniQure NV (QURE)

uniQure NV

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:QURE

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/01/09	06 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QURE	uniQure NV
2025/01/09	06 : 21	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:QURE	uniQure NV
2025/01/08	21 : 05	GlobeNewswire Inc.	uniQure Announces Pricing of its Public Offering	NASDAQ:QURE	uniQure NV
2025/01/08	07 : 25	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:QURE	uniQure NV
2025/01/08	06 : 49	GlobeNewswire Inc.	uniQure Announces Proposed Public Offering	NASDAQ:QURE	uniQure NV
2025/01/08	06 : 42	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:QURE	uniQure NV
2024/12/11	06 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QURE	uniQure NV
2024/12/11	06 : 33	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:QURE	uniQure NV
2024/12/10	21 : 22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QURE	uniQure NV
2024/12/10	21 : 05	GlobeNewswire Inc.	uniQure Announces Alignment with FDA on Key Elements of Accelerated Approval Pathway for AMT-130 in Huntington’s Disease	NASDAQ:QURE	uniQure NV
2024/11/21	23 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QURE	uniQure NV
2024/11/21	21 : 05	GlobeNewswire Inc.	uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe Epilepsy	NASDAQ:QURE	uniQure NV
2024/11/15	02 : 01	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:QURE	uniQure NV
2024/11/05	23 : 08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:QURE	uniQure NV
2024/11/05	22 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QURE	uniQure NV
2024/11/05	21 : 05	GlobeNewswire Inc.	uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress	NASDAQ:QURE	uniQure NV
2024/10/26	10 : 48	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:QURE	uniQure NV
2024/10/26	10 : 48	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:QURE	uniQure NV
2024/10/15	20 : 49	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QURE	uniQure NV
2024/10/15	20 : 05	GlobeNewswire Inc.	uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS	NASDAQ:QURE	uniQure NV
2024/09/23	20 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QURE	uniQure NV
2024/09/23	20 : 05	GlobeNewswire Inc.	uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease	NASDAQ:QURE	uniQure NV
2024/08/15	20 : 48	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QURE	uniQure NV
2024/08/15	20 : 05	GlobeNewswire Inc.	uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease	NASDAQ:QURE	uniQure NV
2024/08/01	21 : 54	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:QURE	uniQure NV
2024/08/01	20 : 51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QURE	uniQure NV
2024/08/01	20 : 43	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:QURE	uniQure NV
2024/08/01	20 : 05	GlobeNewswire Inc.	uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update	NASDAQ:QURE	uniQure NV
2024/07/23	20 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QURE	uniQure NV
2024/07/23	20 : 05	GlobeNewswire Inc.	uniQure Announces Closing of Sale of Manufacturing Facility to Genezen	NASDAQ:QURE	uniQure NV

Showing the most relevant articles for your search:NASDAQ:QURE

1 2 3 4 5 6 7 8 9 10 次へ >>

Health Care Select Sector

US Dollar vs Euro

Energy Select Sector SPDR

American Express

US Dollar vs Sterling

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約